The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, Ethnicity, and Coronary Artery Calcium
Abstract
Background— To assess the implementation challenge facing the Third Report of the Adult Treatment Panel (ATP III) of the National Cholesterol Education Program, we determined the prevalence, treatment, and control of dyslipidemia, including ethnic and gender differences, in persons free of known clinical cardiovascular disease (CVD). In addition, this report provides information about the presence of coronary artery calcium (CAC) across groups defined by risk and recommendations for the use of lipid-lowering drugs. Methods and Results— The Multi-Ethnic Study of Atherosclerosis (MESA) is a multicenter cohort study of 6814 persons aged 45 to 84 years who were free of clinical CVD at baseline (2000–2002). Participants with complete fasting lipid profiles (n=6704) were evaluated for CVD risk and self-reported use of lipid-lowering therapy. CAC was assessed by CT. Drug treatment thresholds and goals were defined according to ATP III. Models were constructed to adjust for age, clinic site, risk factors, socioeconomic characteristics, and healthcare access variables with the use of Poisson regression. Overall, 29.3% (1964/6704) had dyslipidemia, among whom lipid-lowering drug therapy was reported by 54.0% (1060/1964). Control to ATP III goal was observed in 75.2% (797/1060) of participants with treated dyslipidemia and 40.6% (797/1964) of participants with dyslipidemia. Men were more likely than women to qualify for drug therapy and less likely to be treated and controlled. Relative to non-Hispanic whites, Chinese Americans were less likely to qualify for drug treatment, but no differences in treatment and control rates were observed. Black and Hispanic Americans had prevalence of dyslipidemia that was comparable to that of non-Hispanic whites but were less likely to be treated and controlled. Ethnic disparities were attenuated substantially by adjustment for healthcare access variables; however, the gender disparities persisted despite adjustment for risk factors, socioeconomic characteristics, and healthcare access variables. Control of dyslipidemia was achieved less commonly in the CVD high- and intermediate-risk groups than in the low-risk group. Among high-risk individuals, 19.7% of those who did not qualify for lipid-lowering drug treatment had CAC >400. The proportion of drug treatment–qualifying persons who were not treated differed by presence and severity of CAC, with 48.0%, 46.8%, and 39.6% of eligible persons with no CAC, with CAC >0 and <400, and with CAC >400 not receiving treatment, respectively ( P for difference=0.04). Conclusions— Dyslipidemia is common among persons without CVD. The quality of care for dyslipidemia is suboptimal in general and variable by CVD risk group, ethnicity, and gender. The utility of incorporating CAC screening into the risk stratification and treatment process should be investigated in light of the substantial proportions of persons with CAC who are currently classified as not requiring treatment. Research and quality improvement programs are needed to optimize management of dyslipidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,829
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Pearson, T. A., Laurora, I., Chu, H., & Kafonek, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.459 · Cited by 1,012
Breen, J. F., Sheedy, P. F., Schwartz, R. S., Stanson, A. W., Kaufmann, R. B., Moll, P. P., & Rumberger, J. A. (1992) · Radiology · doi:10.1148/radiology.185.2.1410350 · Cited by 274
Raggi, P., Davidson, M., Callister, T. Q., Welty, F. K., Bachmann, G. A., Hecht, H., & Rumberger, J. A. (2005) · Circulation · doi:10.1161/circulationaha.104.512681 · Cited by 271
Sueta, C. A., Chowdhury, M., Boccuzzi, S. J., Smith, S. C., Alexander, C. M., Londhe, A., Lulla, A., & Simpson, R. J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00117-4 · Cited by 266
Carr, J. J., Crouse, J. R., Goff, D. C., D'Agostino, R. B., Peterson, N. P., & Burke, G. L. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.4.1740915 · Cited by 236
Self-citationMcBride, P., Schrott, H. G., Plane, M. B., Underbakke, G., & Brown, R. L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1238 · Cited by 228
Dart, A., Jerums, G., Nicholson, G., d'Emden, M., Hamilton-Craig, I., Tallis, G., Best, J., West, M., Sullivan, D., Braes, P., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00280-4 · Cited by 187
Nieto, F. J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.7.677 · Cited by 169
Hoerger, T. J., Bala, M. V., Bray, J. W., Wilcosky, T. C., & LaRosa, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00227-6 · Cited by 167
Summary health statistics for U.S. adults: National Health Interview Survey, 2002.
Lethbridge‐Çejku, M., Schiller, J. S., & Bernadel, L. (2004) · PubMed · Cited by 139
Cohen, M. V., Byrne, M. J., Levine, B. C., Gutowski, T., & Adelson, R. (1991) · Circulation · doi:10.1161/01.cir.83.4.1294 · Cited by 137
Variations in Cholesterol Management Practices of U.S. Physicians
Stafford, R. S., Blumenthal, D., & Pasternak, R. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00441-x · Cited by 129
Recent Trends in the Identification and Treatment of High Blood Cholesterol by Physicians
Giles, W. H. (1993) · JAMA · doi:10.1001/jama.1993.03500090069035 · Cited by 124
Use and Monitoring of "Statin" Lipid-Lowering Drugs Compared With Guidelines
Abookire, S. A., Karson, A. S., Fiskio, J. M., & Bates, D. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.1.53 · Cited by 115
Giles, W. H. (1993) · JAMA · doi:10.1001/jama.269.9.1133 · Cited by 111
Huang, M.-H., Schocken, M., Block, G., Sowers, M. R., Gold, E. B., Sternfeld, B., Seeman, T. E., & Greendale, G. A. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200209000-00003 · Cited by 81
Healthy people 2010—leading health indicators for women
Maiese, D. R. (2002) · Women s Health Issues · doi:10.1016/s1049-3867(02)00140-8 · Cited by 65
Assessment of Hypercholesterolemia Control in a Managed Care Organization
Straka, R. J., Taheri, R., Cooper, S. L., Tan, A. W. H., & Smith, J. C. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.9.818.34563 · Cited by 54
Wong, N. D., Kawakubo, M., LABREE, L. D., Azen, S. P., Xiang, M., & Detrano, R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.003 · Cited by 51
The Clinical Quality Improvement Network (CQIN) Investigators (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80157-x · Cited by 49
Goff, D. C., Gu, L., Cantley, L. K., Sheedy, D. J., & Cohen, S. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00522-2 · Cited by 39
Self-citationChang, J. J. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg274 · Cited by 39
Massing, M. W., Foley, K. A., Carter‐Edwards, L., Sueta, C. A., Alexander, C. M., & Simpson, R. J. (2004) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-4-15 · Cited by 35
Clinical treatment of dyslipidemia: practice patterns and missed opportunities
Smith, S. C. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01473-9 · Cited by 23
Quilliam, B. J., Perez, H., Andros, V., & Jones, P. J. H. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.3.244 · Cited by 18
Goff, D. C., Gu, L., Cantley, L. K., Parker, D. G., & Cohen, S. J. (2002) · PubMed · Cited by 14
Self-citationBanks, T., & Ali, N. (2001) · PubMed Central · Cited by 6
Cited by
Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147
Self-citationJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Racial/ethnic differences in dyslipidemia patterns
Frank, A. T. H., Zhao, B., Jose, P. O., Azar, K. M. J., Fortmann, S. P., & Palaniappan, L. P. (2014) · Circulation · doi:10.1161/circulationaha.113.005757 · Cited by 327
Metadata
- Authors
- Goff, D. C., Bertoni, A. G., Kramer, H., Bonds, D., Blumenthal, R. S., Tsai, M. Y., & Psaty, B. M.
- Venue
- Circulation
- Published
- 2006-02-07
- Volume
- 113
- Issue
- 5
- Pages
- 647-656
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2165673279
- Cited by
- 316
- References
- 37
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.